IMMX - Financial Reports List - Immix Biopharma, Inc. - IntrinsicAlpha

Immix Biopharma, Inc. IMMX

Healthcare - Biotechnology - NASDAQ - US

$ 1.71

-0.599 %

$ 47.4 M

Market Cap

-2.18

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	5.45%	7.10%
Annual Report	FY	10-K	2024-12-31	0.00%	-40.11%	-40.48%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-67.02%	-63.47%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-22.84%	-26.39%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-110.53%	-123.28%
Quarterly Report	Q4	8-K	2023-12-31	100.01%	-33.94%	-41.48%
Annual Report	FY	10-K	2023-12-31	100.00%	-87.44%	-96.39%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-178.86%	-195.02%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-128.84%	-138.36%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-87.53%	-89.52%

1